Dr. Younger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yaw 9
Boston, MA 02114Phone+1 617-726-6500Fax+1 617-724-1079
Summary
- Dr. Jerry Younger is an oncologist based in Boston, MA specializing in hematologic oncology. He completed his medical education at Washington University in St. Louis School of Medicine, followed by an internship and residency in Internal Medicine at Boston University Medical Center. He further pursued a fellowship in Hematology and Medical Oncology at Duke University Hospital. Since 1980, he has been a physician at Massachusetts General Hospital. Dr. Younger has notable publications focused on breast cancer, contributing to Clinical Cancer Research, Breast Cancer Research, and Annals of Oncology. He received a Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1972 - 1974
- Boston University Medical CenterResidency, Internal Medicine, 1970 - 1972
- Boston University Medical CenterInternship, Internal Medicine, 1969 - 1970
- Washington University in St. Louis School of MedicineClass of 1969
Certifications & Licensure
- MA State Medical License 1973 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 10 citationsTumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.Neelima Vidula, Andrzej Niemierko, Giuliana Malvarosa, Megan Yuen, Jochen K. Lennerz
Clinical Cancer Research. 2021-01-27 - 32 citationsPhase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesJose Pablo Leone, Kyrre E. Emblem, Michelle Weitz, Rebecca Gelman, Bryan P. Schneider
Breast Cancer Research. 2020-11-30 - 10 citationsIdentification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancerNeelima Vidula, Taronish D. Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko
Clinical Cancer Research. 2020-09-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: